Nucleic acid molecules encoding inclusion membrane protein C...

Details Nucleic acid molecules encoding inclusion membrane protein C... Nucleic acid molecules encoding inclusion membrane protein C...

2007-01-23

2007-01-23

Sullivan, Daniel M. (Department: 1636)

Drug, bio-affecting and body treating compositions

Antigen, epitope, or other immunospecific immunoeffector

Bacterium or component thereof or substance produced by said...

C530S324000, C530S325000, C530S326000, C424S185100, C424S190100, C424S192100

Reexamination Certificate

active

10756320

ABSTRACT:
The present invention provides a method of nucleic acid, including DNA, immunization of a host, including humans, against disease caused by infection by a strain ofChlamydia, specificallyC. pneumoniae, employing a vector, containing a nucleotide sequence encoding an inclusion membrane protein C of a strain ofChlamydia pneumoniaeand a promoter to effect expression of the inclusion membrane protein C gene in the host.

REFERENCES:
patent: 4168062 (1979-09-01), McCarthy
patent: 4722848 (1988-02-01), Paoletti et al.
patent: 4882278 (1989-11-01), Mekalanos
patent: 4920209 (1990-04-01), Davis et al.
patent: 4945050 (1990-07-01), Sanford et al.
patent: 4952496 (1990-08-01), Studier et al.
patent: 5015580 (1991-05-01), Christou et al.
patent: 5028530 (1991-07-01), Lai et al.
patent: 5057546 (1991-10-01), Sudan
patent: 5283185 (1994-02-01), Epand et al.
patent: 5364773 (1994-11-01), Paoletti et al.
patent: 5527928 (1996-06-01), Nantz et al.
patent: 187720 (1986-07-01), None
patent: WO 88/06626 (1988-09-01), None
patent: WO 88/09336 (1988-12-01), None
patent: WO 90/00594 (1990-01-01), None
patent: WO 90/11092 (1990-10-01), None
patent: WO 91/00359 (1991-01-01), None
patent: WO 91/13157 (1991-09-01), None
patent: WO 91/15501 (1991-10-01), None
patent: WO 92/01796 (1992-02-01), None
patent: WO 92/11354 (1992-07-01), None
patent: WO 92/11361 (1992-07-01), None
patent: WO 92/21376 (1992-12-01), None
patent: WO 93/17706 (1993-09-01), None
patent: WO 93/18759 (1993-09-01), None
patent: WO 93/19768 (1993-10-01), None
patent: WO 94/01533 (1994-01-01), None
patent: WO 94/16737 (1994-08-01), None
patent: WO 94/19482 (1994-09-01), None
patent: WO 94/21797 (1994-09-01), None
patent: WO 94/24263 (1994-10-01), None
patent: WO 94/25608 (1994-11-01), None
patent: WO 95/02397 (1995-01-01), None
patent: WO 95/17211 (1995-06-01), None
patent: WO 95/26356 (1995-10-01), None
patent: WO 96/06627 (1996-03-01), None
patent: WO 96/14831 (1996-05-01), None
patent: WO 99/27105 (1999-06-01), None
patent: WO 99/28475 (1999-06-01), None
patent: WO 00/27994 (2000-05-01), None
patent: WO 00/34483 (2000-06-01), None
patent: WO 00/37494 (2000-06-01), None
patent: WO 00/46359 (2000-08-01), None
patent: WO 00/66739 (2000-11-01), None
patent: WO 01/21804 (2001-03-01), None
patent: WO 01/21811 (2001-03-01), None
patent: WO 01/40474 (2001-06-01), None
patent: WO 01/46224 (2001-06-01), None
patent: WO 01/81379 (2001-11-01), None
patent: WO 01/85972 (2001-11-01), None
patent: WO 02/02606 (2002-01-01), None
patent: WO 02/08267 (2002-01-01), None
Purcell et al. Dissecting the role of peptides in the immune response: theory, practice and the application to vaccine design. J Pept Sci. May 2003;9(5):255-81.
Richards Protein stability: still an unsolved problem. Cell Mol Life Sci. Oct. 1997;53(10):790-802.
Grayston et al. (1995). Journal of Infectious Diseases 168:1231-1235.
Campos et al. (1995), Investigation of Ophthalmology and Visual Science 36:1477-1491.
Grayston et al (1990), Journal of Infectious Diseases 161:618-625.
Marrie (1993), Clinical Infectious Diseases. 18:501-515.
Wang et al (1986), Chlamydial infections. Cambridge University Press, Cambridge. p. 329-332.
Normann et al., Acta Paediatrica, 1998, vol. 87, Iss 1, pp. 23-27.
Saikku et al.(1988), Lancet:983-985.
Thom et al. (1992), JAMA 268:68-72.
Linnanmaki et al. (1993), Circulation 87:1030-1034.
Saikku et al. (1992), Annals Internal Medicine 116:273-278.
Melnick et al(1993), American Journal of Medicine 95:499-504.
Shor et al. (1992), South African. Medical Journal 82:158-161.
Kuo et al. (1993), Journal of Infectious Diseases 167:841-849.
Kuo et al. (1993), Arteriosclerosis and Thrombosis 13:1500-1504.
Campbell et al (1995), Journal of Infectious Diseases 172:585-588.
Chiu et al. Circulation, 1997 96(7):2144-2148.
Ramirez et al (1996) Annals of Internal Medicine 125:979-982.
Jackson et al. Abst. K121, p. 272, 36th ICAAC, Sep. 15-18 1996, New Orleans.
Fong et al (1997) Journal of Clinical Microbiology 35:48-52.
Hahn DL, et al. Evidence forChlamydia pneumoniaeinfection in steroid-dependent asthma. Ann Allergy Asthma Immunol. Jan. 1998; 80(1): 45-49.
Hahn DL, et al. Association ofChlamydia pneumoniaeIgA antibodies with recently symptomatic asthma. Epidemiol Infect. Dec. 1996; 117(3): 513-517.
Bjornsson E, et al. Serology ofchlamydiain relation to asthma and bronchial hyperresponsiveness. Scand J Infect Dis. 1996; 28(1): 63-69.
Hahn DL. Treatment ofChlamydia pneumoniaeinfection in adult asthma: a before-after trial. J Fam Pract. Oct. 1995; 41(4): 345-351.
Allegra L, et al. Acute exacerbations of asthma in adults: role ofChlamydia pneumoniaeinfection. Eur Respir J. Dec. 1994; 7(12): 2165-2168.
Hahn DL, et al. Association ofChlamydia pneumoniae(strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA. Jul. 10, 1991; 266(2): 225-230.
Pal et al.(1996) Infection and Immunity.64:5341-5348.
Jones et al. (1995) Vaccine 13:715.
Igietseme et al (1993) Regional Immunology 5:317.
Magee et al (1993) Regional Immunology 5: 305-311.
Landers et al (1991) Infection & Immunity 59:3774-3777.
Magee et al (1995) Infection & Immunity 63:516-521.
Cotter et al. (1995) Infection and Immunity63:4704-4714.
Campbell et al (1990) Infection and Immunity 58:93-97.
McCafferty et al (1995) Infection and Immunity 63:2387-2389.
Knudsen et al (1996)Third Meeting of the European Society for Chlamydia Research, Vienna.
Wiedmann-Al-Ahmad M, et al. Reactions of polyclonal and neutralizing anti-p54 monoclonal antibodies with an isolated, species-specific 54-kilodalton protein of Chlamydia pneumonlae. Clin Diagn Lab Immunol. Nov. 1997; 4(6): 700-704.
Hughes et al., 1992. Infect. Immun. 60(9):3497-3503.
Dion et al., 1990. Virology 179:474-477.
Snijders et al., 1991. J. Gen. Virol. 72:557-565.
Langeveld et al., Vaccine 12(15):1473-1480, 1994.
Ausubel et al., Current Protocols in Molecular Biology, John Wiley & Sons Inc., 1994.
Kunkel et al. Proc. Natl. Acad. Sci. USA (1985) 82:488-492.
Silhavy et al. Experiments with Gene Fusions, Cold Spring Harbor Laboratory Press, 1984.
Davis et al. A Manual for Genetic Engineering: Advanced Bacterial Genetics, Cold Spring Harbor Laboratory Press, 1980).
Casey & Davidson, Nucl. Acid Res. (1977) 4:1539-1553.
Cagnon et al., Protein Engineering (1991) 4(7):843-847.
Takase et al., J. Bact. (1987) 169:5692-5699.
Perez Melgosa et al., Infect Immun (1994) 62:880-886.
Watson et al., Nucleic Acids Res (1990) 18:5299.
Watson et al., Microbiology (1995) 141:2489-2497.
Melgosa et al., FEMS Microbiol Lett (1993) 112 :199-204.
Campbell et al., J Clin Microbiol (1990) 28 :1261.1264.
Iijima et al., J Clin Microbiol (1994) 32:583.-588.
Tartaglia et al, Virology (1992) 188:217-232.
Taylor et al, Vaccine (1995) 15:359.
Kieny et al., Nature (1994) 312:163.
Mekalanos et al., Nature (1983) 306:551-557.
Nakayama et al., Bio/Tech. (1988) 6:693-697.
High et al., EMBO (1992) 11:1991-1999.
Sizemore et al., Science (1995) 270:299-302.
Medaglini et al., Pro. Natl. Acad. Sci. USA (1995) 92:6868-6872.
Flynn J.L., Cell. Mol. Biol. (1994) 40 (suppl. I):31-36.
Norton & Coffin, Molec. Cell Biol. (1985) 5:281-290.
Li et al., Gene (1989) 78:243-254.
Li & Paulin, J. Biol. Chem. (1991) 266:6562-6570.
Li & Paulin, J. Biol. Chem. (1993) 268:10403-10415.
Hartikka et al., Human Gene Therapy (1996) 7:1205-1217.
Tang et al., Nature (1992) 356:152-154.
Davis et al., Vaccine 1994, 12:1503-1509.
Nielsen et al., Science (1991) 254:1497-1500.
Southern, J. Mol. Biol. (1975) 98:503-517.
Dunn et al., Cell (1977) 12:23-36.
Towbin et al., Proc. Natl. Acad. Sci. USA (1779) 76:4350-4354.
Laemmli, Nature (1970) 227:680-685.
Bachmaier et al., Science (1999) 283:1335-1338.
Yang et al., 1993, Infection & Immunity, vol. 61, pp. 2037-2040.
Chi E.Y., Kuo C.C., Grayston J.T., 1987. Unique ultrastructure in the elementary body ofChlamydiasp strain TWAR. J. Bacteriol 169(8): 3757-63.
Needleman, S.B., and Wunsch, C.D. 1970, J. Mol Biol. 48:443-453.
Sellers, P.H. 1974 On the theory and computation of evolutionary distances. J. Appl. Math(Siam) 26:787-793.
Waterman, M.S., Smit

Affiliated with

Also associated with

Rating

Nucleic acid molecules encoding inclusion membrane protein C... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Nucleic acid molecules encoding inclusion membrane protein C..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleic acid molecules encoding inclusion membrane protein C... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3728381